Entry
Name
EREG-overexpression to RAS-ERK signaling pathway
Definition
EREG* -> EGFR -> GRB2 -> SOS -> RAS -> RAF -> MEK -> ERK
Expanded
2069v1 -> 1956 -> 2885 -> (6654,6655) -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595)
Class
Type
Variant
Pathway
Disease
Gene
1956 EGFR; epidermal growth factor receptor
2885 GRB2; growth factor receptor bound protein 2
6654 SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1
6655 SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2
3265 HRAS; HRas proto-oncogene, GTPase
3845 KRAS; KRAS proto-oncogene, GTPase
4893 NRAS; NRAS proto-oncogene, GTPase
369 ARAF; A-Raf proto-oncogene, serine/threonine kinase
673 BRAF; B-Raf proto-oncogene, serine/threonine kinase
5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
5604 MAP2K1; mitogen-activated protein kinase kinase 1
5605 MAP2K2; mitogen-activated protein kinase kinase 2
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
Variant
2069v1 (EREG*) EREG overexpression
Reference
Authors
Dasari A, Messersmith WA
Title
New strategies in colorectal cancer: biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways.
Journal
Reference
Authors
Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW
Title
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer.
Journal
Reference
Authors
Yarom N, Jonker DJ
Title
The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.
Journal
Discov Med 11:95-105 (2011)
LinkDB
All DBs